Guaiphenesin is also known as Guaifenesin is an expectorant drug usually taken orally to assist the expectoration ('bringing up') of phlegm from the airways in acute respiratory tract infections.
Guaiphenesin Market contains market size and forecasts of Guaiphenesin in Global, including the following market information:
- Global Guaiphenesin Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Guaiphenesin market was valued at 77 million in 2021 and is projected to reach US$ 99.2 million by 2028, at a CAGR of 3.7% during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Active Pharmaceutical Ingredients Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Guaiphenesin include EMS Pharmaceutical, Mission Pharma, Orbis Biosciences, Sovereign Pharma, Lipocine Inc, Kowa, RB Pharma, Elan and Granules, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Guaiphenesin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Guaiphenesin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Guaiphenesin Market Segment Percentages, by Type, 2021 (%)
- Active Pharmaceutical Ingredients
- Preparation
Global Guaiphenesin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Guaiphenesin Market Segment Percentages, by Application, 2021 (%)
- Chronic Bronchitis With Phlegm
- Bronchiectasis
- Infection
- Other
Global Guaiphenesin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Guaiphenesin Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Guaiphenesin revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Guaiphenesin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- EMS Pharmaceutical
- Mission Pharma
- Orbis Biosciences
- Sovereign Pharma
- Lipocine Inc
- Kowa
- RB Pharma
- Elan
- Granules
- Synthokem Labs
- Haizhou Pharma
- Prasco
- Camlin Fine Science
- Gennex Lab
- Iwaki Seiyaku
- Pan Drugs
- Smart Pharm
- Silarx Pharmaceuticals
- Meda Pharmaceuticals (Mylan)
- Aurohealth LLC
- Enzymatic Therapy
- Seven Star Pharma
Industry Market Size
